Another X-linked tumor suppressor gene recurrently mutated in our cohort was PHF6. PHF6 mutations are rare events in pediatric AML, as only 1.4% to 3.6% of patients harbor PHF6 mutations with an associated poor outcome.13 This evidence concerns the gene PHF6 and acute myeloid leukemia.